Search results
Forget Mykonos and Santorini, Syros is the best Greek island. Here are 10 of my favorite things to...
INSIDER via Yahoo News· 1 month agoSyros is a charming Greek island near Mykonos. Joanna Kalafatis Syros, a short ferry ride from...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript November 14, 2023...
individual investors who own 35% along with institutions invested in Syros Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Syros Pharmaceuticals' significant individual investors ownership suggests that the key...
Syros Pharmaceuticals, Inc. (SYRS) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) might move higher on growing optimism about its earnings...
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
Zacks via Yahoo Finance· 6 months agoSyros (SYRS) posts encouraging initial data from the phase II SELECT-AML-1 study evaluating...
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -28.57% and 34.25%,...
One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year
Simply Wall St. via Yahoo Finance· 1 year agoViewing insider transactions for Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS ) over the last year, we...
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...
Zacks via Yahoo Finance· 1 month agoSyros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a...
Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline...
Steven Cohen's Point72 Asset Management Acquires New Stake in Syros Pharmaceuticals
GuruFocus.com via Yahoo Finance· 5 months agoSteven Cohen (Trades, Portfolio)'s Point72 Asset Management has recently made a significant...